733 results about "Cell typing" patented technology

The invention provides a cell type and cell abundance identification method and system based on cross-modal training, relates to the field of image processing, and aims to solve the problems that the existing identification technology mostly depends on non-standard factors such as manual labeling position annotation information and the like, abundant morphological modes in a tissue pathological image are not fully utilized, and the identification accuracy is poor. And the identification reliability and accuracy are influenced. The method comprises the following steps: acquiring spatial transcriptomics data matched with pathological image-gene expression, and preprocessing the spatial transcriptomics data to obtain high-expression gene expression data, local image blocks, cell types and abundance tags; constructing a cross-modal joint representation learning model, and inputting high-expression gene expression data and local image blocks into the model for training; and predicting a to-be-predicted histological image based on the trained model. According to the method, the problems in the prior art are solved, the capability of predicting the cell abundance from the histological image is improved, and the spatial distribution of fine-grained cell types is fully revealed.

A spatial omics multi-modal fusion method under a single cell level comprises the following steps: extracting spatial morphological characteristics of differential expression genes and cell nucleuses from spatial transcriptome data, single cell sequencing data and histological images, and realizing field adaptation among different platforms by using a conditional variation auto-encoder. And based on a probability inference model, fusing spatial transcriptome expression, unicellular omics and morphological characteristics, and jointly inferring the type and gene expression level of each cell. A spatial cell network is constructed through a graph attention mechanism, and spatial diffusion and recognition of cell types in a full slice range are realized. In combination with a multi-omics enhancement module, undetected gene and protein expression is completed based on expression similarity, and prediction consistency is improved through spatial correction. According to the method, high-resolution reconstruction of single-cell multi-omics information in a three-dimensional space is realized, the information coverage and spatial resolution of spatial omics data are improved, and an efficient and low-cost solution is provided for spatial biology and precise medical research.

The invention provides a biological microenvironment image analysis and classification method, which relates to the technical field of cell image analysis and comprises the following steps: processing an input biological microenvironment image, segmenting cell components and extracting multi-parameter initial features of the cell components; a first machine learning model is adopted to deduce a refined functional sub-state exceeding a traditional cell type based on the internal characteristics and local microenvironment information of the cells; in combination with biomolecule interaction knowledge, calculating and generating a spatially resolved biomolecule interaction potential field map so as to quantify intercellular communication potential; forming a comprehensive state descriptor set; and inputting the descriptor set into a second machine learning classification model to generate a precise classification result of the biological microenvironment. According to the method, functional, quantitative and interpretable analysis and classification of the biological microenvironment are realized, and the evaluation depth, objectivity and accuracy are remarkably improved.

The invention relates to the technical field of bioinformatics, and provides a visual analysis method and system for a rice multi-tissue single cell expression profile. The method comprises the following steps: comparing sequencing data of an original single cell transcriptome of a rice tissue to obtain a standardized transcriptome data set; performing batch effect correction and integration on the standardized transcriptome data set to obtain a whole plant expression matrix; performing cell type annotation on the whole plant expression matrix to obtain a cell type annotation system; carrying out visual dimension reduction processing on the whole plant expression matrix fused with the cell type annotation system, and carrying out co-expression network construction to obtain a modular tissue correlation analysis model; and establishing an interaction end based on the module organization correlation analysis model, and realizing data visualization analysis through the interaction end. The invention provides a one-stop analysis platform for rice cell heterogeneity research, functional gene mining and molecular breeding.

The invention belongs to the technical field of biology, and particularly relates to a nano antibody-proximity marker enzyme fusion protein and application thereof. Specifically, the present disclosure provides a fusion protein for proximity labeling wherein the fusion protein is operably linked together by (a) a nanobody and (b) a proximity labeling enzyme; optionally, a peptide linker is also included between the nano antibody and the proximity marker enzyme. The nano antibody-proximity marker enzyme fusion protein disclosed by the invention is obtained through in-vitro expression and purification, target protein is targeted by using an antibody, and the nano antibody-proximity marker enzyme fusion protein does not depend on an overexpression system and has compatibility to various cell types, tissues and clinical fixed samples; proteins with post-translational modification and various organelles, such as membraneless organelles, can be targeted; and the positioning accuracy rate reaches 100%.

The invention discloses a spatial transcriptomics cell clustering method based on multi-scale contrast learning. The method comprises the following steps: S1, carrying out data preprocessing; s2, performing graph construction by using the processed data; s3, performing data enhancement; s4, extracting cell gene expression information by using GCN; s5, enriching node information by using a ContraNorm layer; and S6, further learning information by using multi-scale image comparison learning, and performing biological analysis by using final information obtained by learning. According to the method, computer-aided cell type analysis is utilized, a large amount of high-quality data is not needed, only gene expression data and cell space position information data are utilized, which cells belong to the same category can be predicted, and more effective information is provided to help researchers to identify the onset of cancer and the development of diseases.

The invention provides a spatial domain identification method based on data interpolation and cell type deconvolution, and belongs to the technical field of bioinformatics. In order to solve the problems that gap information between adjacent points cannot be utilized in low-resolution spatial transcriptome data and prior information of cell types in a tissue space structure level cannot be fully integrated in a traditional method, the method comprises the following steps: acquiring a spatial transcriptome data set and a single-cell RNA sequencing data set, and performing data preprocessing on the acquired data sets; and carrying out data interpolation on the preprocessed spatial transcriptome data, and carrying out cell type deconvolution in combination with single-cell RNA sequencing data. And constructing a deep learning model based on the graph convolutional network. And training a deep learning model according to gene expression information, spatial position information and cell type information of the spatial transcriptome data after cell type deconvolution by using a self-supervised contrast learning strategy. And performing spatial domain identification on the to-be-detected data based on the trained model.

The invention provides a cell type annotation method and device, equipment and a storage medium, and the method comprises the steps: clustering cell sequencing data into a plurality of cell populations; analyzing a differential high-expression component list of each cell population, wherein the differential high-expression component list comprises differential high-expression components (components refer to genes or proteins) which are ranked from high to low according to specificity scores in the cell populations; for each cell population, determining the probability that the cell population belongs to each cell type according to the sequence of the preset marking component corresponding to each cell type in the difference high expression component list of the cell population, and determining the cell type with the maximum corresponding probability as the cell type to which the cell population belongs; the sorting of the marked components corresponding to the cell types in the differential high-expression component list of the cell population is positively correlated with the probability that the cell population belongs to the cell types. According to the scheme, the influence of the marking component on the cell type to which the cell population belongs is correspondingly enhanced or weakened according to the specificity of the marking component in the cell population, and the accuracy of the annotation result is improved.

The invention discloses a 3D intestinal organ differentiation method based on human pluripotent stem cells and an induction culture medium and application thereof, and relates to the technical field of stem cells. According to a culture medium formula combination, intestinal organs can be differentiated into various cell types such as epithelial cells, neuroendocrine cells and endothelial cells; the method is a key mark for successful differentiation and functional maturation of intestinal organs. According to the 3D intestinal organ differentiation method disclosed by the invention, histological structures such as intestinal crypts are differentiated from intestinal organs generated by differentiation, and the intestinal organs can creep in a maintenance stage, so that the intestinal organs are changed from structural bionics to functional simulation, and the significance of the 3D intestinal organ differentiation method is far better than that of pure morphological simulation. Through a systematic culture medium formula, a clear operation process and a multi-stage induction strategy, the 3D intestinal organ with structural integrity, cell diversity and functional activity is successfully constructed, and the system provides an efficient, reliable and extensible in-vitro model platform for intestinal biological research and related application.

The invention provides a single-cell multi-omics cell type annotation method based on distribution and knowledge alignment, and belongs to the technical field of single-cell type annotation, the method comprises the following steps: obtaining single-cell transcriptome data and single-cell chromatin accessibility sequencing data, and pre-training and training a multi-omics variation auto-encoder model, the multi-omics variational auto-encoder model is combined with a variational auto-encoder and a knowledge distillation technology, and multi-omics single cell data is integrated and annotated through distribution and knowledge alignment. And performing cell type prediction on the single cell transcriptome data and the single cell chromatin accessibility sequencing data which are input at the same time by using the trained multi-omics variational auto-encoder model. According to the method, the problem of limitation of a method only depending on single omics is solved, the synergistic effect between the omics is enhanced, the accuracy of annotation is improved, and the calculation overhead is reduced through knowledge distillation.

The invention relates to the technical field of cell data analysis, and discloses a single-cell transcriptome data and text description conjoint analysis method based on a multi-modal language model, which comprises the following steps: acquiring a single-cell RNA sequencing expression matrix and a corresponding cell text description, preprocessing the single-cell RNA sequencing expression matrix and the corresponding cell text description, and analyzing the single-cell transcriptome data and the corresponding cell text description; according to the method, a multi-modal data set is constructed, deep fusion of gene expression data and text knowledge is realized by constructing a double-model and cross-modal projection module, limitation of a single mode is avoided, a gene expression value and an index sequence are reserved during preprocessing, a rough coding mode is changed, and the cell type identification accuracy is improved; based on a pre-training strategy of comparative learning, matching learning and a cross-modal projection module, fine-grained cross-modal information interaction and sharing are realized, and cross-modal task effects of text generation cells or cell generation texts and the like are optimized.

The invention provides a cell specific transcription factor regulatory network analysis method and a visualization platform, and relates to the technical field of bioinformatics, the method comprises the following steps: constructing a gene regulatory network through a GRNBoost2-cisTarget-AUCell-Cell GRN workflow based on a transcription factor in combination with a motif database; screening a direct regulation relationship in combination with the database, and calculating an activity score of a regulator in each cell; based on activity scores and cell type annotation results, grouping the single cell data by using a unified manifold approximation and projection (UMAP) dimensionality reduction method and a Leiden clustering algorithm, and displaying the following results through an interactive visualization tool: a cell clustering UMAP graph, performing color marking according to cell types; a UMAP graph and a heat map of transcription factor regulator activity; according to the visual map of the gene regulation and control network, transcription factors and target genes are distinguished through node shapes, and regulation and control relations are marked through line weights and colors. According to the invention, an accurate regulation and control network can be provided.

The invention discloses a key marker gene-based intelligent cell type annotation method, which comprises the following steps of: constructing a static knowledge base by using known marker genes in a reference database, and endowing the marker genes with cell specific weights by using a TF-IDF method, so that the annotation accuracy and interpretability are improved. Meanwhile, under the condition that static matching is insufficient, the literature is understood through a large language model, mark information is extracted, dynamic completion of the knowledge base is achieved, the defect that updating of a traditional knowledge base is lagged is overcome, and good adaptability and expansibility are achieved. Besides, static and dynamic matching scores are fused in the annotation process, so that more robust cell type identification is realized, annotation requirements of multi-tissue, multi-species and novel cell states are adapted, high-precision and extensible cell type annotation can be realized in a scene with insufficient reference knowledge or a fuzzy sample, and the annotation efficiency is improved. And the method has good universality and practicability.

The embodiment of the invention relates to the technical field of bioinformatics, and provides a bulk data cell analysis method, device and equipment, and the method comprises the following steps: constructing an initial reference matrix according to a single cell data set and a cell type annotation template, each element in the initial reference matrix represents the gene expression quantity of each cell state under each characteristic gene; performing deconvolution on the bulk data to be analyzed according to the initial reference matrix to obtain a first deconvolution result; updating the initial reference matrix according to the first deconvolution result to obtain a first reference matrix; and according to the first reference matrix, performing deconvolution on the bulk data to be analyzed to obtain a second proportion and a second gene expression quantity of each cell type in the bulk data to be analyzed. According to the embodiment of the invention, the accuracy of cell analysis in bulk data can be improved.

The invention discloses a method for constructing a differential diagnosis model for lupus nephritis and membranous nephropathy, and belongs to the technical field of intelligent medical treatment. The modeling method comprises the following steps: S1, respectively collecting flow cytometry detection data of lupus nephritis patients and healthy control personnel; s2, performing data cleaning and conversion on the flow cytometry detection data, and converting non-numerical features into digits; carrying out implication on the missing value by adopting a k nearest neighbor algorithm from an implication packet; s3, random sampling is carried out on the cleaned and converted data set, and samples are divided into a training set and a verification set according to the proportion of 7: 3; s4, dividing a training subset and a test set from the training set, and iteratively selecting the types of cells incorporated into the constructed model as pDC, CD4T, effector CD4T, Th2, CD8T, CD38 + HLA-DR + CD8T, and CD38 + PD-1 + CD8T by adopting an RFE method, wherein the types of the cells incorporated into the constructed model are pDC, CD4T, effector CD4T, Th2, CD8T, CD38 + HLA-DR + CD8T and CD38 + PD-1 + CD8T; and S5, performing a classification task by adopting TabPFNClassifier, performing training from features selected from the training data set, then evaluating the performance of the model, performing model training by utilizing detection data, and performing evaluation to construct a lupus nephritis prediction model with high accuracy.

The invention belongs to the technical field of gene editing, and discloses a gene editing system and application. The invention provides a gene editing system. The gene editing system comprises Cas9 nickase, sgRNA (small guide ribonucleic acid) and annular petRNA. According to the present invention, the target chain cutting mediated reverse pilot editing (Split Reverse Prime Editing, srPE) realizes the precise editing of the non-target chain cutting site upstream sequence, such that the gene editing coverage range is expanded from the specific region only limited to the non-target chain cutting site downstream to the whole genome range, the stable and efficient editing ability is maintained in different cell types, and the target chain cutting mediated reverse pilot editing can be provided for the target chain cutting site. And meanwhile, the off-target risk is reduced. The srPE gene editing technology breaks through the fundamental limitation of the prior art, and provides a more comprehensive and more efficient technical tool for precise medicine and gene therapy.

The invention provides a multi-modal medical image real-time labeling and collaborative browsing method and device based on adaptive DeepZoom and a readable storage medium thereof. A multi-resolution pyramid is constructed, a medical image is downsampled into multiple resolution levels layer by layer, each layer is divided into standard size blocks, dynamic loading is carried out based on a window, and cache management is carried out through an LRU algorithm. The problems of loading lagging and memory overflow of the GB-level image are solved; real-time synchronization of multi-user labeling operation is achieved through a WebSocket protocol, a three-level semantic label system containing lesion areas, cell types and tissue grading is supported, labeling conflicts are solved in combination with a timestamp priority strategy, and version backtracking is supported; a medical compliance log system is designed, information such as cases is recorded, and the whole operation process can be traced through synchronization of local Sqlite cache and cloud HIPAA encryption. According to the method, the medical image browsing efficiency and the labeling collaboration are remarkably improved, and the medical data compliance requirement is met.

The invention discloses an animal single cell data cell type annotation method, which is characterized by comprising the following steps: collecting Bulk RNA-seq data of purified cell types in various tissues and organs of a specific animal, and integrating the Bulk RNA-seq data into a reference data set after preprocessing; the method comprises the following steps: acquiring single-cell RNA-seq original data, screening the single-cell RNA-seq original data to obtain high-quality cells, screening high-variation genes from the high-quality cells, processing the high-variation genes, extracting principal components, performing dimensionality reduction on the principal components, and performing cell clustering based on a dimensionality reduction result to obtain cell clusters; and calculating expression similarity between the cell clusters and the reference data set based on the high-variation genes, determining initial cell types of the cell clusters according to a similarity result, and carrying out iterative tuning on the initial cell types with similar scores to obtain a final cell type annotation result. The method provides efficient and accurate technical support for animal single cell research.

The present invention relates to the intersection of bioinformatics and computational biology, and discloses a transcriptome annotation method and system based on a large language model, including: fusing single-cell spatial coordinates and gene expression values ​​into pseudo-image modal data, extracting spatial topological features of the pseudo-image modal data; performing cross-modal alignment between the spatial topological features and a preset medical database, and analyzing the cell type probability of the cross-modal embedding vector; constructing a functional semantic space of functional description texts, and projecting non-model species into the functional semantic space; calculating the semantic similarity between gene expression embeddings and homologous genes of reference species, and using a large language model to convert gene expression embeddings into semantic mapping relationships. The present invention reduces the core problems faced in single-cell spatial transcriptome annotation, such as extensive spatial topological modeling, low cross-modal alignment accuracy, limited non-model species annotation, and rigid semantic mapping.

The present invention relates to an integrated system for automating cell culture processes. The system combines artificial intelligence (AI) with a robotic apparatus to execute tasks typically performed manually in cell culture laboratories. The AI module employs machine learning algorithms trained on extensive datasets, enabling it to make informed decisions regarding cell culture conditions and protocols for a variety of cell types. An accompanying robotic system performs liquid handling tasks such as media changes and cell passaging with precision. The system is compatible with multiple types of cell culture vessels, facilitating bulk processing. Additionally, an enclosed sterile environment is maintained to prevent contamination. A user interface allows for the customization of protocols and remote monitoring, enhancing operational efficiency. This invention streamlines cell culture workflows, reduces manual labor, and increases the reproducibility and scalability of cell culture.

The invention discloses a senescent cell recognition system and method based on mitochondrial morphology. The system is a classification network, and the input data of the system is a distribution image of mitochondria in subcellular level cells, the distribution image of mitochondria in cells, the shape and / or number of mitochondria distributed at different positions in a three-dimensional structure for displaying cells, and preferably the shape and number of mitochondria distributed at different positions in the three-dimensional structure for displaying cells. According to the senescence cell recognition system based on the mitochondrial morphology, the senescence cells jointly show mitochondrial morphological changes including mitochondrial distribution, mitochondrial shapes and mitochondrial number changes, the senescence cell recognition method is easy to conduct through computer vision, good robustness is achieved, and the senescence cell recognition system based on the mitochondrial morphology is suitable for being applied to senescence cell recognition. Compared with other senescence cell identification methods based on cell nucleus morphological characteristics, the senescence cell identification method based on the general characteristics of the senescence cells has good universality for different cell types.

The invention discloses a method for automatically constructing a pathological image data set and training cell nucleus detection and classification based on a space transcriptome technology, and belongs to the field of image processing and artificial intelligence auxiliary pathological diagnosis. According to the method, a spatial transcriptome public data set is obtained, and a data set containing image blocks, weak supervision / semi-supervision labels and cell nucleus boundary information is automatically constructed through preprocessing, deconvolution cell type annotation and cell nucleus instance segmentation, so that the dependence on manual annotation is reduced. Furthermore, a detection and classification model is designed, a multi-scale deformable attention encoder and a decoupled detection and classification decoder are adopted, a limited deformable cross attention mechanism is introduced into the classification decoder, KL divergence classification loss is combined, and instance-level cell nucleus categories are learned from region-level proportion labels. According to the method, end-to-end automation is realized, the cell nucleus detection and classification precision and efficiency are improved, and a high-quality pre-training model basis is provided for downstream pathological analysis.

The application provides a single-cell transcriptome cell annotation method and system of a fusion large language model, cell type annotation is performed through construction of special prompt words and use of a large language model, and the accuracy and universality of cell annotation are improved. The application has a significant advantage for cell annotation of non-model species, and realizes an automatic and intelligent cell annotation process.

Described herein are compositions, kits, and methods for potent delivery to a cell of a subject. The cell can be of a particular cell type, such as a basal cell, a ciliated cell, or a secretory cell. In some cases, the cell can be a lung cell of a particular cell type. Also described herein are pharmaceutical compositions comprising a therapeutic or prophylactic agent assembled with a lipid composition. The lipid composition can comprise an ionizable cationic lipid, a phospholipid, and a selective organ targeting lipid. Further described herein are high-potency dosage forms of a therapeutic or prophylactic agent formulated with a lipid composition.

The invention provides a cell type annotation method and device based on plant single cell transcriptome data and a readable storage medium. Annotation is achieved through multi-level data integration, wherein preliminary annotation is expressed based on cell type marker genes or homologous genes; calculating expression correlation auxiliary annotations of the to-be-analyzed data and the known transcriptome data set; performing function enrichment on the cell cluster differential genes to deduce cell types; carrying out quasi-timing analysis on the heterogeneous cell clusters and annotating subgroups; and finally integrating and generating a comprehensive annotation. The method solves the problem that the prior art depends on artificial experience and is insufficient in basic data set, and is suitable for mode and non-mode plants.

The present invention relates to novel biomarkers for cell type-specific and / or organ-specific extracellular vesicles, in particular brain-specific and / or neuron-specific extracellular vesicles, and combinations thereof. The invention also provides methods for isolating and / or enriching cell type-specific and / or organ-specific extracellular vesicles, methods for identifying cell-derived extracellular vesicles, and methods for diagnosing or prognosing a disorder (e.g., a neurodegenerative disorder) using cell type-specific and / or organ-specific extracellular vesicles. Also provided are compositions in the form of kits for detecting cell type-specific and / or organ-specific extracellular vesicles.

Provided is a method for screening myocardial therapeutic targets for ischemic heart failure by using single-cell sequencing, which method comprises the following steps: S1, sample preparation; S2, construction of a single-cell expression matrix; S3, cell quality control; S4, cell type annotation; S5, cell communication analysis; and S6, co-expression network analysis. The provided method for screening myocardial therapeutic targets for ischemic heart failure by using single-cell sequencing comprises performing single-cell sequencing on hearts of healthy mice and IHF mice, screening for cell types with significant differences in cardiac transcriptional profiles of the healthy mice and IHF mice, then exploring interaction characteristics of various types of cells in malignant fibrotic IHF hearts, revealing potential regulatory modules and pathways related to malignant myocardial fibrosis in single-cell expression data of IHF hearts, and performing screening to obtain Pdgfb and Tnfsf12 genes which can be used as therapeutic targets for treating myocardial fibrosis in ischemic heart failure.

The invention is applicable to the technical field of cell type annotation, and provides an interpretable single cell annotation method, which comprises the following steps: based on a source cancer data set, performing cell type label prediction on a target cancer data set through a first module of an annotation model to obtain a prediction label of each cell in the target cancer data set, the annotation model is constructed by adopting an information bottleneck-based graph interpretation technology, and based on the health data set and the prediction label, interpretability analysis is performed on the to-be-interpreted cancer data set through a second module of the annotation model to obtain an interpretation result, the to-be-explained cancer data set is composed of the cancer cell gene expression matrix and the prediction label of the target cancer data set, so that the explanatory mechanism is integrated into the model architecture, the prediction accuracy is ensured, the explanatory stability and reliability are improved, the inconsistency caused by dependence on a post explanatory method is avoided, and the prediction accuracy is improved. And the prediction logic of the model can be understood.

The invention relates to the technical field of biomedical engineering, in particular to a separated type organ-like chip model and a use method thereof.The model comprises a chip, an organ-like unit module and a fluid control system, and the use method comprises the steps that firstly, the chip is assembled and prepared; step 2, cell inoculation and culture; step 3, establishing and operating a fluid circulation system; step 4, organ-like unit function detection and data acquisition; 5, analyzing an experimental result and adjusting the model; the model is connected with a micro-fluidic channel through an independent cavity, and the characteristics, cell types and culture conditions of a cell culture bracket can be regulated and controlled according to the characteristics of simulated organs. Meanwhile, the micro-fluidic channel ensures stable and ordered material exchange among the organoid units, and is beneficial to more accurately screening out effective treatment schemes and drug targets.

The invention discloses a method and system for evaluating the treatment effect of traditional Chinese medicine based on single cell and spatial transcriptome data, and the method comprises the following steps: respectively obtaining single cell data and spatial transcriptome data of a tissue sample before and after administration, and carrying out the preprocessing; classifying the cells and identifying cell types; the expressed ligand and receptor genes are paired to obtain ligand-receptor pairs, and the ligand-receptor pairs which are differentially expressed before and after administration are screened out; acquiring space coordinate information of a single cell, and constructing a cell interaction network and a differential gene network according to the cell type, the ligand-receptor pair and the space coordinate information; weighting processing is conducted on the cell interaction network and the differential gene network, and comprehensive indexes for evaluating the effect of the traditional Chinese medicine are obtained.The brand-new method for evaluating the disease treatment effect of the traditional Chinese medicine is provided, the method is scientific and reliable, and the treatment effect of the traditional Chinese medicine on complex diseases can be accurately reflected.